67184-0513 : Irinotecan Hydrochloride 20 mg/ml Intravenous Injection, Solution


NDC: 67184-0513
Labeler: Qilu Pharmaceutical Co., Ltd.
Product Type: Human Prescription Drug
Drug Name:  Irinotecan Hydrochloride
Dosage Form: Intravenous Injection, Solution
Application #: ANDA203380
Rev. Date: 


NDC Package Codes:

  • 67184-0513-1: 1 VIAL, SINGLE‑USE IN 1 CARTON (67184‑0513‑1) > 15 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Irinotecan Hydrochloride

Dosage Strength:

  • 20 mg/mL

Pharmaceutical Classes:

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 67184-0511 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection, Solution by Qilu Pharmaceutical Co., Ltd.
  • 67184-0512 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection, Solution by Qilu Pharmaceutical Co., Ltd.
  • 0143-9583 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0143-9701 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0143-9702 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0703-4432 Irinotecan Hydrochloride 40 mg/2ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0703-4434 Irinotecan Hydrochloride 100 mg/5ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 16714-027 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Northstar Rx LLC
  • 16714-131 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Northstar Rx LLC
  • 16714-725 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Northstar Rxllc
  • 16714-726 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Northstar Rxllc
  • 23155-179 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Heritage Pharmaceuticals Inc.
  • 25021-214 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 25021-230 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 45963-614 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection, Solution by Actavis Pharma, Inc.
  • 47335-937 Irinotecan Hydrochloride 40 mg/2ml Intravenous Injection by Sun Pharma Global Fze
  • 47335-953 Irinotecan Hydrochloride 100 mg/5ml Intravenous Injection by Sun Pharma Global Fze
  • 50742-401 Irinotecan Hydrochloride 40 mg/2ml Intravenous Injection by Ingenus Pharmaceuticals, LLC
  • 50742-402 Irinotecan Hydrochloride 100 mg/5ml Intravenous Injection by Ingenus Pharmaceuticals, LLC
  • 53104-0151 Irinotecan Hydrochloride 20 mg/ml Intravenous Injection by Cipla Limited
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 67184-0513 QR Code

< Prev: 67184-0512Next: 67184-0514 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.